Cabot Corporation
CBT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,139,430 | $4,012,500 | $4,489,560 | $4,958,133 |
| - Cash | $239,000 | $239,000 | $213,000 | $183,000 |
| + Debt | $1,215,000 | $1,215,000 | $1,289,000 | $1,198,000 |
| Enterprise Value | $5,115,430 | $4,988,500 | $5,565,560 | $5,973,133 |
| Revenue | $899,000 | $923,000 | $936,000 | $955,000 |
| % Growth | -2.6% | -1.4% | -2% | – |
| Gross Profit | $220,000 | $244,000 | $241,000 | $235,000 |
| % Margin | 24.5% | 26.4% | 25.7% | 24.6% |
| EBITDA | $175,000 | $213,000 | $208,000 | $199,000 |
| % Margin | 19.5% | 23.1% | 22.2% | 20.8% |
| Net Income | $43,000 | $101,000 | $94,000 | $93,000 |
| % Margin | 4.8% | 10.9% | 10% | 9.7% |
| EPS Diluted | 0.8 | 1.86 | 1.69 | 1.67 |
| % Growth | -57% | 10.1% | 1.2% | – |
| Operating Cash Flow | $219,000 | $249,000 | $73,000 | $124,000 |
| Capital Expenditures | -$64,000 | -$34,000 | -$99,000 | -$77,000 |
| Free Cash Flow | $155,000 | $215,000 | -$26,000 | $47,000 |